EBF1-PDGFRB fusion
|
ALL
|
EBF1-PDGFRB fusion
|
ALL
|
imatinib Sensitive: C4 – Case Studies
|
imatinib Sensitive: C4 – Case Studies
|
EBF1-PDGFRB fusion
|
B Acute Lymphoblastic Leukemia
|
EBF1-PDGFRB fusion
|
B Acute Lymphoblastic Leukemia
|
imatinib Sensitive: C4 – Case Studies
|
imatinib Sensitive: C4 – Case Studies
|
EBF1-PDGFRB fusion
|
Childhood B Acute Lymphoblastic Leukemia
|
EBF1-PDGFRB fusion
|
Childhood B Acute Lymphoblastic Leukemia
|
dasatinib Sensitive: D – Preclinical
|
dasatinib Sensitive: D – Preclinical
|